Author
Universidade de Santiago de CompostelaORCID 0000-0002-7158-4459Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Thais Pereira‐Veiga, Celso Yáñez-Gómez, Aleksi Pekkarinen…·Clotilde Costa
This study shows that red blood cells from cancer patients enhance tumour cell invasiveness and metastatic potential through gene and protein changes, suggesting PAK4 as a therapeutic target.
Sandra Amarilla‐Quintana, Paloma Navarro, Iván Hernández…·Ignacío Pérez de Castro
This study uses CRISPR to eliminate the FOXL2 c.402C>G mutation in granulosa tumor cells, reducing malignancy and identifying anti-tumoral compounds.
Ana Quelle‐Regaldie, Nerea Gandoy-Fieiras, Paula R. Villamayor…·María Jesús Sobrido
This paper describes a zebrafish model of NPC1 deficiency with a C-terminal mutation, showing severe phenotypes and altered lipid metabolism.